Carregant...
Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement
Limited therapeutic options are available to amyloid patients treated with many lines of therapy. Although combination therapy using lenalidomide and dexamethasone is an effective sequential regimen for systemic amyloidosis (AL), dexamethasone is often poorly tolerated in patients with cardiac invol...
Guardat en:
| Publicat a: | J Clin Med Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elmer Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554222/ https://ncbi.nlm.nih.gov/pubmed/26346623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2303e |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|